Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov;45(11):17-24.
doi: 10.1097/01.NPR.0000718508.65708.a1.

Infectious complications of newer agents in the fight against diabetes

Kayla R Stover, Emily Hugh, Justin J Sherman, Scott S Malinowski, Gideon J Berdahl, Daniel M Riche
Review

Infectious complications of newer agents in the fight against diabetes

Kayla R Stover et al. Nurse Pract. 2020 Nov.

Abstract

Infectious complications have been reported with antidiabetic medications. Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors have been associated with upper respiratory tract infections and urinary tract infections. Sodium-glucose cotransporter 2 inhibitors have been associated with lower limb amputations, urinary tract infections, genital mycotic infections, and Fournier gangrene.

PubMed Disclaimer

References

    1. National Diabetes Statistics Report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. www.cdc.gov/diabetes/data/statistics-report/index.html?CDC_AA_refVal=htt....
    1. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H. Infection and diabetes: the case for glucose control. Am J Med. 1982;72(3):439–450. doi:10.1016/0002-9343(82)90511-3.
    1. Zaccardi F, Webb DR, Yates T, Davies MJ. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J. 2016;92(1084):63–69. doi:10.1136/postgradmedj-2015-133281.
    1. Boyko EJ, Lipsky BA, Sandoval R, et al. NIDDM and prevalence of nasal Staphylococcus aureus colonization. San Luis Valley Diabetes Study. Diabetes Care. 1989;12(3):189–192. doi:10.2337/diacare.12.3.189.
    1. Hart J, Hamilton EJ, Makepeace A, et al. Prevalence, risk factors and sequelae of Staphylococcus aureus carriage in diabetes: the Fremantle Diabetes Study Phase II. J Diabetes Complications. 2015;29(8):1092–1097. doi:10.1016/j.jdiacomp.2015.06.005

MeSH terms

Substances